{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:59:15Z","timestamp":1785113955147,"version":"3.55.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Chem"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    X-ray crystallographic fragment screening is a powerful strategy in modern drug discovery, enabling the identification of small-molecule starting points for rational hit-to-lead optimization. While highly effective for soluble proteins, its application to membrane proteins remains challenging due to low expression yields, high hydrophobicity, and the complexities of crystallization\u2014particularly when using lipid cubic phase (LCP), which is often essential for high-resolution structural studies of targets like G-protein-coupled receptors (GPCRs). In this study, we present a methodology that integrates high-throughput X-ray crystallography with computational modeling and complementary biophysical validation to overcome these barriers. Using a thermostabilized human adenosine A\n                    <jats:sub>2A<\/jats:sub>\n                    receptor crystallized in LCP as a test system, we screened 568 fragments and identified 23 initial hits. The work represents the first large-scale fragment screening effort targeting crystals of a membrane protein grown in LCP. Structure-guided virtual screening of these hits led to the design of 109 follow-up compounds, of which 56 yielded crystal structures. Of these, 19 were additionally confirmed to bind by grating-coupled interferometry (GCI), providing complementary biophysical validation. Our results demonstrated the feasibility and effectiveness of this integrated approach for fragment-based drug discovery on membrane proteins crystallized in LCP. Moreover, the detection of ligands at a previously uncharacterized intracellular pocket in a GPCR highlights the potential of this strategy to accelerate the discovery of therapeutically relevant compounds for challenging drug targets.\n                  <\/jats:p>","DOI":"10.1038\/s42004-026-02059-7","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:38:09Z","timestamp":1778693889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An integrated experimental and computational pipeline for crystallographic fragment screening of membrane protein in the lipid cubic phase"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7676-0239","authenticated-orcid":false,"given":"Chia-Ying","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7564-1230","authenticated-orcid":false,"given":"Robert","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Bucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Andres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Bacchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6558-8878","authenticated-orcid":false,"given":"Hannah","family":"Glover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1481-9514","authenticated-orcid":false,"given":"Christoph P.","family":"Sager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5340-3036","authenticated-orcid":false,"given":"Meitian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6157-3687","authenticated-orcid":false,"given":"Michel O.","family":"Steinmetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1839-2351","authenticated-orcid":false,"given":"Michael","family":"Hennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3880-7438","authenticated-orcid":false,"given":"May","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"2059_CR1","doi-asserted-by":"crossref","unstructured":"Renaud, J.-P. (ed.) Structural Biology in Drug Discovery (John Wiley & Sons, Nashville, TN, 2020).","DOI":"10.1002\/9781118681121"},{"key":"2059_CR2","doi-asserted-by":"publisher","unstructured":"Majorek, K. A. et al. Assessment of crystallographic structure quality and protein\u2013ligand complex structure validation. Struct. Biol. Drug Discov. https:\/\/doi.org\/10.1002\/9781118681121.ch11 (2020).","DOI":"10.1002\/9781118681121.ch11"},{"key":"2059_CR3","doi-asserted-by":"crossref","unstructured":"Davies, T. G. & Hyv\u00f6nen, M. (eds.) Fragment-Based Drug Discovery and X-Ray Crystallography (Springer, Berlin, Germany, 2012).","DOI":"10.1007\/978-3-642-27540-1"},{"key":"2059_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18709-w","volume":"11","author":"A Douangamath","year":"2020","unstructured":"Douangamath, A. et al. Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease. Nat. Commun. 11, 5047 (2020).","journal-title":"Nat. Commun."},{"key":"2059_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf8711","volume":"7","author":"M Schuller","year":"2021","unstructured":"Schuller, M. et al. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci. Adv. 7, eabf8711 (2021).","journal-title":"Sci. Adv."},{"key":"2059_CR6","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s11224-022-02031-w","volume":"33","author":"DM Teli","year":"2022","unstructured":"Teli, D. M., Patel, B. & Chhabria, M. T. Fragment-based design of SARS-CoV-2 Mpro inhibitors. Struct. Chem. 33, 2155\u20132168 (2022).","journal-title":"Struct. Chem."},{"key":"2059_CR7","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1021\/acs.jcim.3c00409","volume":"63","author":"LC Saramago","year":"2023","unstructured":"Saramago, L. C. et al. AI-driven discovery of SARS-CoV-2 main protease fragment-like inhibitors with antiviral activity in vitro. J. Chem. Inf. Model. 63, 2866\u20132880 (2023).","journal-title":"J. Chem. Inf. Model."},{"key":"2059_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1107\/S2059798324000329","volume":"80","author":"CY Huang","year":"2024","unstructured":"Huang, C. Y. et al. Fragment-based screening targeting an open form of the SARS-CoV-2 main protease binding pocket. Acta Crystallogr. D Struct. Biol. 80, 123\u2013136 (2024).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"2059_CR9","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1021\/acsmedchemlett.4c00238","volume":"15","author":"AJ Taylor","year":"2024","unstructured":"Taylor, A. J. et al. Fragment-based screen of SARS-CoV-2 papain-like protease (PLpro). ACS Med. Chem. Lett. 15, 1351\u20131357 (2024).","journal-title":"ACS Med. Chem. Lett."},{"key":"2059_CR10","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd.2017.178","volume":"16","author":"AS Hauser","year":"2017","unstructured":"Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schi\u00f6th, H. B. & Gloriam, D. E. Trends in GPCR drug discovery: new agents, targets and indications. Nat. Rev. Drug Discov. 16, 829\u2013842 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2059_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/17460441.2023.2216014","volume":"18","author":"V Casad\u00f3","year":"2023","unstructured":"Casad\u00f3, V. & Casad\u00f3-Anguera, V. What are the current trends in G protein-coupled receptor targeted drug discovery? Expert Opin. Drug Discov. 18, 815\u2013820 (2023).","journal-title":"Expert Opin. Drug Discov."},{"key":"2059_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","volume":"9","author":"M Zhang","year":"2024","unstructured":"Zhang, M. et al. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery. Signal Transduct. Target. Ther. 9, 88 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2059_CR13","doi-asserted-by":"publisher","first-page":"12305","DOI":"10.1039\/D1CC03202J","volume":"57","author":"P Matricon","year":"2021","unstructured":"Matricon, P. et al. Fragment-based design of selective GPCR ligands guided by free energy simulations. Chem. Commun. 57, 12305\u201312308 (2021).","journal-title":"Chem. Commun."},{"key":"2059_CR14","doi-asserted-by":"publisher","first-page":"11173","DOI":"10.1021\/jacs.3c00972","volume":"145","author":"JM Mattheisen","year":"2023","unstructured":"Mattheisen, J. M. et al. Bioorthogonal tethering enhances drug fragment affinity for G protein-coupled receptors in live cells. J. Am. Chem. Soc. 145, 11173\u201311184 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"2059_CR15","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nprot.2009.31","volume":"4","author":"M Caffrey","year":"2009","unstructured":"Caffrey, M. & Cherezov, V. Crystallizing membrane proteins using lipidic mesophases. Nat. Protoc. 4, 706\u2013731 (2009).","journal-title":"Nat. Protoc."},{"key":"2059_CR16","doi-asserted-by":"publisher","unstructured":"Liu, W. & Cherezov, V. Crystallization of membrane proteins in lipidic mesophases. J. Vis. Exp. https:\/\/doi.org\/10.3791\/2501 (2011).","DOI":"10.3791\/2501"},{"key":"2059_CR17","doi-asserted-by":"publisher","first-page":"6266","DOI":"10.1021\/bi300010w","volume":"51","author":"M Caffrey","year":"2012","unstructured":"Caffrey, M., Li, D. & Dukkipati, A. Membrane protein structure determination using crystallography and lipidic mesophases: recent advances and successes. Biochemistry 51, 6266\u20136288 (2012).","journal-title":"Biochemistry"},{"key":"2059_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1107\/S2053230X14026843","volume":"71","author":"M Caffrey","year":"2015","unstructured":"Caffrey, M. A comprehensive review of the lipid cubic phase or in meso method for crystallizing membrane and soluble proteins and complexes. Acta Crystallogr. F Struct. Biol. Commun. 71, 3\u201318 (2015).","journal-title":"Acta Crystallogr. F Struct. Biol. Commun."},{"key":"2059_CR19","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1021\/jm400140q","volume":"56","author":"JA Christopher","year":"2013","unstructured":"Christopher, J. A. et al. Biophysical fragment screening of the \u03b21-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug design. J. Med. Chem. 56, 3446\u20133455 (2013).","journal-title":"J. Med. Chem."},{"key":"2059_CR20","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1021\/acs.jmedchem.5b00892","volume":"58","author":"JA Christopher","year":"2015","unstructured":"Christopher, J. A. et al. Fragment and structure-based drug discovery for a class C GPCR: discovery of the mGlu5 negative allosteric modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile). J. Med. Chem. 58, 6653\u20136664 (2015).","journal-title":"J. Med. Chem."},{"key":"2059_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18570-w","volume":"8","author":"P Rucktooa","year":"2018","unstructured":"Rucktooa, P. et al. Towards high throughput GPCR crystallography: in Meso soaking of Adenosine A2A Receptor crystals. Sci. Rep. 8, 41 (2018).","journal-title":"Sci. Rep."},{"key":"2059_CR22","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3390\/cryst12070976","volume":"12","author":"Z Luo","year":"2022","unstructured":"Luo, Z., Gu, W., Wang, Y., Tang, Y. & Li, D. Selenourea for experimental phasing of membrane protein crystals grown in lipid cubic phase. Crystals (Basel) 12, 976 (2022).","journal-title":"Crystals (Basel)"},{"key":"2059_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.chemphyslip.2007.03.005","volume":"147","author":"S Abe","year":"2007","unstructured":"Abe, S. & Takahashi, H. A comparative study of the effects of dimethylsulfoxide and glycerol on the bicontinuous cubic structure of hydrated monoolein and its phase behavior. Chem. Phys. Lipids 147, 59\u201368 (2007).","journal-title":"Chem. Phys. Lipids"},{"key":"2059_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1107\/S2059798315021683","volume":"72","author":"CY Huang","year":"2016","unstructured":"Huang, C. Y. et al. In meso in situ serial X-ray crystallography of soluble and membrane proteins at cryogenic temperatures. Acta Crystallogr. D Struct. Biol. 72, 93\u2013112 (2016).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"2059_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s42003-018-0123-6","volume":"1","author":"C-Y Huang","year":"2018","unstructured":"Huang, C.-Y. et al. In situ serial crystallography for rapid de novo membrane protein structure determination. Commun. Biol. 1, 124 (2018).","journal-title":"Commun. Biol."},{"key":"2059_CR26","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.str.2018.10.027","volume":"27","author":"A-K Apel","year":"2019","unstructured":"Apel, A.-K. et al. Crystal structure of CC chemokine receptor 2A in complex with an orthosteric antagonist provides insights for the design of selective antagonists. Structure 27, 427\u2013438.e5 (2019).","journal-title":"Structure"},{"key":"2059_CR27","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/febs.15098","volume":"287","author":"R Cheng","year":"2020","unstructured":"Cheng, R., Huang, C.-Y., Hennig, M., Nar, H. & Schnapp, G. In situ crystallography as an emerging method for structure solution of membrane proteins: the case of CCR2A. FEBS J. 287, 866\u2013873 (2020).","journal-title":"FEBS J."},{"key":"2059_CR28","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1107\/S2052252519013137","volume":"6","author":"A Ishchenko","year":"2019","unstructured":"Ishchenko, A. et al. Toward G protein-coupled receptor structure-based drug design using X-ray lasers. IUCrJ 6, 1106\u20131119 (2019).","journal-title":"IUCrJ"},{"key":"2059_CR29","doi-asserted-by":"crossref","unstructured":"Healey, R. D. et al. An automated platform for structural analysis of membrane proteins through serial crystallography. Cell Rep. Methods. 1, None (2021).","DOI":"10.1101\/2021.06.03.446146"},{"key":"2059_CR30","doi-asserted-by":"publisher","first-page":"6470","DOI":"10.1021\/acs.jmedchem.6b00653","volume":"59","author":"E Segala","year":"2016","unstructured":"Segala, E. et al. Controlling the dissociation of ligands from the adenosine A2A receptor through modulation of salt bridge strength. J. Med. Chem. 59, 6470\u20136479 (2016).","journal-title":"J. Med. Chem."},{"key":"2059_CR31","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/s41586-024-07153-1","volume":"629","author":"MM Papasergi-Scott","year":"2024","unstructured":"Papasergi-Scott, M. M. et al. Time-resolved cryo-EM of G-protein activation by a GPCR. Nature 629, 1182\u20131191 (2024).","journal-title":"Nature"},{"key":"2059_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56434-4","volume":"16","author":"M Bi","year":"2025","unstructured":"Bi, M. et al. Structure and function of a near fully-activated intermediate GPCR-G\u03b1\u03b2\u03b3 complex. Nat. Commun. 16, 1100 (2025).","journal-title":"Nat. Commun."},{"key":"2059_CR33","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1107\/S2059798322000705","volume":"78","author":"JW Kaminski","year":"2022","unstructured":"Kaminski, J. W. et al. Fast fragment- and compound-screening pipeline at the Swiss Light Source. Acta Crystallogr. D Struct. Biol. 78, 328\u2013336 (2022).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"2059_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/bs.mie.2023.08.005","volume":"690","author":"DP Stegmann","year":"2023","unstructured":"Stegmann, D. P., Steuber, J., Fritz, G., Wojdyla, J. A. & Sharpe, M. E. Fast fragment and compound screening pipeline at the Swiss Light Source. Methods Enzymol 690, 235\u2013284 (2023).","journal-title":"Methods Enzymol"},{"key":"2059_CR35","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1476-5381.1995.tb15923.x","volume":"115","author":"SM Poucher","year":"1995","unstructured":"Poucher, S. M. et al. The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist. Br. J. Pharmacol. 115, 1096\u20131102 (1995).","journal-title":"Br. J. Pharmacol."},{"key":"2059_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/PL00005326","volume":"359","author":"E Ongini","year":"1999","unstructured":"Ongini, E., Dionisotti, S., Gessi, S., Irenius, E. & Fredholm, B. B. Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors. Naunyn. Schmiedebergs. Arch. Pharmacol. 359, 7\u201310 (1999).","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"2059_CR37","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1126\/science.1164772","volume":"322","author":"V-P Jaakola","year":"2008","unstructured":"Jaakola, V.-P. et al. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322, 1211\u20131217 (2008).","journal-title":"Science"},{"key":"2059_CR38","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1177\/24725552211013827","volume":"26","author":"\u00d6 Kartal","year":"2021","unstructured":"Kartal, \u00d6, Andres, F., Lai, M. P., Nehme, R. & Cottier, K. WaveRAPID-A robust assay for high-throughput kinetic screens with the creoptix WAVEsystem. SLAS Discov. 26, 995\u20131003 (2021).","journal-title":"SLAS Discov."},{"key":"2059_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1107\/S2059798320014114","volume":"77","author":"ND Wright","year":"2021","unstructured":"Wright, N. D. et al. The low-cost Shifter microscope stage transforms the speed and robustness of protein crystal harvesting. Acta Crystallogr. D Struct. Biol. 77, 62\u201374 (2021).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"2059_CR40","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1021\/ja512751q","volume":"137","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. J. Am. Chem. Soc. 137, 2695\u20132703 (2015).","journal-title":"J. Am. Chem. Soc."},{"key":"2059_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s42004-022-00721-4","volume":"5","author":"I Alibay","year":"2022","unstructured":"Alibay, I., Magarkar, A., Seeliger, D. & Biggin, P. C. Evaluating the use of absolute binding free energy in the fragment optimisation process. Commun. Chem. 5, 105 (2022).","journal-title":"Commun. Chem."},{"key":"2059_CR42","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1021\/acschembio.5b01034","volume":"11","author":"J Schiebel","year":"2016","unstructured":"Schiebel, J. et al. Six biophysical screening methods miss a large proportion of crystallographically discovered fragment hits: a case study. ACS Chem. Biol. 11, 1693\u20131701 (2016).","journal-title":"ACS Chem. Biol."},{"key":"2059_CR43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nature08615","volume":"462","author":"JS Fraser","year":"2009","unstructured":"Fraser, J. S. et al. Hidden alternative structures of proline isomerase essential for catalysis. Nature 462, 669\u2013673 (2009).","journal-title":"Nature"},{"key":"2059_CR44","doi-asserted-by":"publisher","first-page":"16247","DOI":"10.1073\/pnas.1111325108","volume":"108","author":"JS Fraser","year":"2011","unstructured":"Fraser, J. S. et al. Accessing protein conformational ensembles using room-temperature X-ray crystallography. Proc. Natl. Acad. Sci. USA. 108, 16247\u201316252 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2059_CR45","doi-asserted-by":"publisher","first-page":"07574","DOI":"10.7554\/eLife.07574","volume":"4","author":"DA Keedy","year":"2015","unstructured":"Keedy, D. A. et al. Mapping the conformational landscape of a dynamic enzyme by multitemperature and XFEL crystallography. Elife 4, 07574 (2015).","journal-title":"Elife"},{"key":"2059_CR46","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/cbic.201500196","volume":"16","author":"M Fischer","year":"2015","unstructured":"Fischer, M., Shoichet, B. K. & Fraser, J. S. One crystal, two temperatures: cryocooling penalties alter ligand binding to transient protein sites. Chembiochem 16, 1560\u20131564 (2015).","journal-title":"Chembiochem"},{"key":"2059_CR47","doi-asserted-by":"publisher","first-page":"e36307","DOI":"10.7554\/eLife.36307","volume":"7","author":"DA Keedy","year":"2018","unstructured":"Keedy, D. A. et al. An expanded allosteric network in PTP1B by multitemperature crystallography, fragment screening, and covalent tethering. Elife 7, e36307 (2018).","journal-title":"Elife"},{"key":"2059_CR48","doi-asserted-by":"publisher","first-page":"e84632","DOI":"10.7554\/eLife.84632","volume":"12","author":"T Skaist Mehlman","year":"2023","unstructured":"Skaist Mehlman, T. et al. Room-temperature crystallography reveals altered binding of small-molecule fragments to PTP1B. Elife 12, e84632 (2023).","journal-title":"Elife"},{"key":"2059_CR49","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1107\/S2059798324006697","volume":"80","author":"CY Huang","year":"2024","unstructured":"Huang, C. Y., Aumonier, S., Olieric, V. & Wang, M. Cryo2RT: a high-throughput method for room-temperature macromolecular crystallography from cryo-cooled crystals. Acta Crystallogr. D Struct. Biol. 80, 620\u2013628 (2024).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"2059_CR50","doi-asserted-by":"publisher","first-page":"12857","DOI":"10.3390\/ijms131012857","volume":"13","author":"Z Chilingaryan","year":"2012","unstructured":"Chilingaryan, Z., Yin, Z. & Oakley, A. J. Fragment-based screening by protein crystallography: successes and pitfalls. Int. J. Mol. Sci. 13, 12857\u201312879 (2012).","journal-title":"Int. J. Mol. Sci."},{"key":"2059_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/128_2011_179","volume":"317","author":"TG Davies","year":"2012","unstructured":"Davies, T. G. & Tickle, I. J. Fragment screening using X-ray crystallography. Top. Curr. Chem. 317, 33\u201359 (2012).","journal-title":"Top. Curr. Chem."},{"key":"2059_CR52","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/1087057112465979","volume":"18","author":"J Wielens","year":"2013","unstructured":"Wielens, J. et al. Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?: do differences in methodology affect hit identification? J. Biomol. Screen. 18, 147\u2013159 (2013).","journal-title":"J. Biomol. Screen."},{"key":"2059_CR53","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pbiomolbio.2014.08.004","volume":"116","author":"D Patel","year":"2014","unstructured":"Patel, D., Bauman, J. D. & Arnold, E. Advantages of crystallographic fragment screening: functional and mechanistic insights from a powerful platform for efficient drug discovery. Prog. Biophys. Mol. Biol. 116, 92\u2013100 (2014).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"2059_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79226-w","volume":"10","author":"H Jankovics","year":"2020","unstructured":"Jankovics, H. et al. Grating-coupled interferometry reveals binding kinetics and affinities of Ni ions to genetically engineered protein layers. Sci. Rep. 10, 22253 (2020).","journal-title":"Sci. Rep."},{"key":"2059_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrd.2016.230","volume":"16","author":"R Santos","year":"2017","unstructured":"Santos, R. et al. A comprehensive map of molecular drug targets. Nat. Rev. Drug Discov. 16, 19\u201334 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2059_CR56","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/ci500588j","volume":"55","author":"T Sander","year":"2015","unstructured":"Sander, T., Freyss, J., von Korff, M. & Rufener, C. DataWarrior: an open-source program for chemistry aware data visualization and analysis. J. Chem. Inf. Model. 55, 460\u2013473 (2015).","journal-title":"J. Chem. Inf. Model."},{"key":"2059_CR57","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.tips.2018.03.002","volume":"39","author":"NV Ortiz Zacar\u00edas","year":"2018","unstructured":"Ortiz Zacar\u00edas, N. V., Lenselink, E. B., IJzerman, A. P., Handel, T. M. & Heitman, L. H. Intracellular receptor modulation: novel approach to target GPCRs. Trends Pharmacol. Sci. 39, 547\u2013559 (2018).","journal-title":"Trends Pharmacol. Sci."},{"key":"2059_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55109-w","volume":"15","author":"H Glover","year":"2024","unstructured":"Glover, H. et al. Photoswitch dissociation from a G protein-coupled receptor resolved by time-resolved serial crystallography. Nat. Commun. 15, 10837 (2024).","journal-title":"Nat. Commun."},{"key":"2059_CR59","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1107\/S1600577523002631","volume":"30","author":"KML Smith","year":"2023","unstructured":"Smith, K. M. L. et al. SDU - software for high-throughput automated data collection at the Swiss Light Source. J. Synchrotron Radiat. 30, 538\u2013545 (2023).","journal-title":"J. Synchrotron Radiat."},{"key":"2059_CR60","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1107\/S0909049509004361","volume":"16","author":"JM Holton","year":"2009","unstructured":"Holton, J. M. A beginner\u2019s guide to radiation damage. J. Synchrotron Radiat. 16, 133\u2013142 (2009).","journal-title":"J. Synchrotron Radiat."},{"key":"2059_CR61","doi-asserted-by":"crossref","unstructured":"Kabsch, W. X. D. S. Acta Crystallogr. D Biol. Crystallogr. 66, 125\u2013132 (2010).","DOI":"10.1107\/S0907444909047337"},{"key":"2059_CR62","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1107\/S0907444911007773","volume":"67","author":"C Vonrhein","year":"2011","unstructured":"Vonrhein, C. et al. Data processing and analysis with the autoPROC toolbox. Acta Crystallogr. D Biol. Crystallogr. 67, 293\u2013302 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2059_CR63","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1107\/S2059798323003595","volume":"79","author":"J Agirre","year":"2023","unstructured":"Agirre, J. et al. The CCP4 suite: integrative software for macromolecular crystallography. Acta Crystallogr. D Struct. Biol. 79, 449\u2013461 (2023).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"2059_CR64","doi-asserted-by":"publisher","first-page":"032104","DOI":"10.1063\/1.4974176","volume":"4","author":"NM Pearce","year":"2017","unstructured":"Pearce, N. M. et al. Partial-occupancy binders identified by the Pan-Dataset Density Analysis method offer new chemical opportunities and reveal cryptic binding sites. Struct. Dyn. 4, 032104 (2017).","journal-title":"Struct. Dyn."},{"key":"2059_CR65","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2059_CR66","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"2059_CR67","unstructured":"Bricogne, G., Blanc, E., Brandl, M., Flensburg, C. & Keller, P. BUSTER Version 2.10. (Global Phasing Ltd, Cambridge, England. 2011)."},{"key":"2059_CR68","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","volume":"67","author":"GN Murshudov","year":"2011","unstructured":"Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D Biol. Crystallogr. 67, 355\u2013367 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2059_CR69","unstructured":"PyMOL. The PyMOL Molecular Graphics System, Version 3.0 (Schr\u00f6dinger, LLC) (2024)."},{"key":"2059_CR70","doi-asserted-by":"publisher","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","volume":"53","author":"S Kim","year":"2024","unstructured":"Kim, S. et al. PubChem 2025 update. Nucleic Acids Res. 53, D1516\u2013D1525 (2024).","journal-title":"Nucleic Acids Res."},{"key":"2059_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003571","volume":"10","author":"S Ruiz-Carmona","year":"2014","unstructured":"Ruiz-Carmona, S. et al. rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acids. PLoS Comput. Biol. 10, e1003571 (2014).","journal-title":"PLoS Comput. Biol."},{"key":"2059_CR72","unstructured":"Schmidtke, P. Tethered minimization of small molecules with RDKit. Discngine https:\/\/www.discngine.com\/blog\/2019\/6\/6\/tethered-minimization-of-small-molecules-with-rdkit-towards-tethered-docking-on-proteins-with-rdock (2019)."},{"key":"2059_CR73","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/bioinformatics\/btr055","volume":"27","author":"G Neudert","year":"2011","unstructured":"Neudert, G. & Klebe, G. fconv: format conversion, manipulation and feature computation of molecular data. Bioinformatics 27, 1021\u20131022 (2011).","journal-title":"Bioinformatics"},{"key":"2059_CR74","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1021\/ci200274q","volume":"51","author":"G Neudert","year":"2011","unstructured":"Neudert, G. & Klebe, G. DSX: a knowledge-based scoring function for the assessment of protein-ligand complexes. J. Chem. Inf. Model. 51, 2731\u20132745 (2011).","journal-title":"J. Chem. Inf. Model."}],"container-title":["Communications Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42004-026-02059-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42004-026-02059-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42004-026-02059-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:02:40Z","timestamp":1785110560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42004-026-02059-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2059"],"URL":"https:\/\/doi.org\/10.1038\/s42004-026-02059-7","relation":{},"ISSN":["2399-3669"],"issn-type":[{"value":"2399-3669","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"257"}}